Translation research of theranostic radiopharmaceuticals: Status at the ININ Mexico

Dr. Guillermina Ferro-Flores
National Institute of Nuclear Research, Mexico
Monday, March 18, 2019 - 11:00am
Pharmacy Building Room 1210
Dr. Guillermina Ferro-Flores is a researcher and scientific leader of the radiopharmacy and medical physics in nuclear medicine research teams at the National Institute of Nuclear Research (ININ) in Mexico, as well as a professor in the Physicomathematical Sciences (Medical Physics) graduate program at the National Polytechnical Institute (IPN) in Mexico City. She received her BSc in Pharmaceutical Chemistry from the Autonomous National University of Mexico (UNAM) and her PhD (DrSc) in Medical Physics from the Autonomous University of the State of Mexico (UAEM). She conducted research stays at the Japan Atomic Energy Research Institute (Department of Radioisotopes) and at the University of Massachusetts Medical School (Nuclear Medicine Department). Her research is focused on the development of radiolabeled probes for molecular imaging and targeted radiotherapy, from which more than 100 peer-reviewed journal articles, 6 book chapters, and 5 patents have been published; one under a broad international patent protection in-licensing to Advanced Nuclear Medicine Ingredients SA (“ANMI”), a wholly-owned subsidiary of Telix Pharmaceuticals Limited. Guillermina Ferro-Flores has reviewed more than 100 articles in peer-reviewed international journals and is a member of the editorial board of the "Contrast Media & Molecular Imaging" journal. She has served as thesis advisor for 26 bachelor's, 7 master's and 10 doctoral theses.
Dr. Raymond Reilly
Centre for Pharmaceutical Oncology